(HealthDay)—For patients with recurrent Clostridium difficile infection (RCDI), fecal microbial transplantation (FMT) with oral capsules is noninferior to FMT by colonoscopy, according to a study published in the Nov. 28 ...
Nov 29, 2017
0
2
After suffering repeated bouts of debilitating Clostridium difficile infections, many patients significantly change their behaviors, but some precautions may do little to prevent future infections, according to a first-of-its-kind ...
Nov 6, 2017
0
0
Outpatient antibiotic use is a primary risk factor for acquiring Clostridium difficile infection in the community, reinforcing the need for appropriate prescribing in this setting, a new study published in Open Forum Infectious ...
Oct 26, 2017
0
0
When facing a life-threatening infection, the "yuck factor" is a minor concern. Fecal microbiota transplant (FMT for short) has become an accepted treatment for recurrent Clostridium difficile infection, which can cause severe ...
Apr 12, 2017
0
5
New research by scientists at the University of Maryland School of Medicine (UM SOM) and the University of Maryland School of Dentistry (UM SOD), is highlighted in a special issue of Pathogens and Disease.
Jan 18, 2017
0
0
Researchers at the University Health Network have found that when treating recurrent Clostridium difficile infection (RCDI), a single fecal transplantation delivered by enema is no more effective than the existing standard ...
Jan 4, 2017
0
0
Results from a placebo-controlled trial provide a strategy for improving fecal microbiota transplantation (FMT) for patients with recurrent Clostridium difficile infection. The study, published online this week in mBio, an ...
Dec 20, 2016
0
0
(HealthDay)—Use of fecal microbiota transplantation (FMT) is cost-effective for recurrent Clostridium difficile infection (CDI), according to a study published in the December issue of the Journal of Gastroenterology and ...
Dec 12, 2016
0
1
It may be possible to safely prevent one of the most common - and costly to treat - infections contracted by hospitalized patients undergoing bone marrow transplantation for the treatment of blood cancers, according to a ...
Nov 28, 2016
0
0
International pharmaceutical company Merck has announced that the U.S. Food and Drug Administration (FDA) has approved Zinplava (its brand name for bezlotoxumab) to reduce recurrence of Clostridium difficile infection (CDI) ...
Oct 25, 2016
0
2
